A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Clinical trial NCT07169994 · RECRUITING

Trial details

NCT number: NCT07169994
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Breast Cancer Non Small Cell Lung Cancer

Start date: 2025-09-02
Primary completion: 2026-09-01
Enrollment: 414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.